Chia Seed Allergy: Emerging Clinical Evidence, Molecular Allergens, and the Unresolved Question of Cross-Reactivity
Corina Porr, Anca Vidrighin, Alina Camelia Catana, Emi Marinela Preda, Valentin-Cristian Iovin, Gabriela Mariana Iancu, Dana M. Harris, Cosmina Diaconu · 2026
Read Chia Seed Allergy: Emerging Clinical Evidence, Molecular Allergens, and the Unresolved Question of Cross-Reactivity by Corina Porr, Anca Vidrighin, Alina Camelia Catana, Emi Marinela Preda, Valentin-Cristian Iovin, Gabriela Mariana Iancu, Dana M. Harris, Cosmina Diaconu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610422.txt.
Description
Corina Porr and co-authors review, in a 2026 paper, what is known about allergy to chia seed, a food now in wide use. Proof of harm is thin: a few case reports, meet talks, and one case series. Those tell of fast reactions tied to IgE antibodies, skin signs, and in some cases full anaphylaxis. Lab work names candidate culprit proteins in four families, such as 2S albumins and oleosins. Tests show IgE can bind them, and cross-binding with sesame shows up as well.
That lab cross-talk does not prove a true cross-allergy in the clinic, the team stresses. No sound data yet set how common chia allergy is, how it runs over time, or what dose sparks a reaction. Set test extracts and dose bars are still lacking. The team calls for clinic studies and sharper protein work.
Catalog record
| CREATOR | Corina Porr, Anca Vidrighin, Alina Camelia Catana, Emi Marinela Preda, Valentin-Cristian Iovin, Gabriela Mariana Iancu, Dana M. Harris, Cosmina Diaconu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |